Guardant Health Inc
(NAS:GH)
$
23.52
-0.08 (-0.34%)
Market Cap: 2.89 Bil
Enterprise Value: 3.22 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 69/100 Guardant Health Inc at Leerink Global Healthcare Conference Transcript
Feb 26, 2020 / 06:30PM GMT
Release Date Price:
$81.5
(+7.53%)
Puneet Souda
SVB Leerink LLC, Research Division - MD of Life Science Tools & Diagnostics and Senior Research Analyst
Okay. I think we can go ahead and get started. All right. So it's a pleasure to have the Guardant team here with me: Helmy Eltoukhy, CEO; Derek Bertocci, CFO. Welcome to SVB Leerink Conference.
Helmy Eltoukhy
Guardant Health, Inc. - Co-Founder, CEO & Director
Thanks for having us, yes.
Questions & Answers
Puneet Souda
SVB Leerink LLC, Research Division - MD of Life Science Tools & Diagnostics and Senior Research Analyst
Yes, absolutely. So -- so the first one, Helmy, a lot to cover today. I have to sort of start with the quarter, given that it was just 2 days ago that's when you reported. The first question here is -- I mean, this clinical volume was strong. You had 78% year-over-year growth in the fourth quarter there. The caution that investors have, after delivering almost like 180% top line revenue growth in the second quarter; 155% in the third quarter; in revenue, the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot